Source: Annual Congress 2010 - New aspects of cystic fibrosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
J. Bradley, S. Blume, M. Balp, S. Elborn (Newtownabbey, United Kingdom; Wisconsin, United States Of America; Basel, Switzerland). Incidence and resource utilisation of pulmonary exacerbations in patients with cystic fibrosis in the UK. Eur Respir J 2010; 36: Suppl. 54, 4801

Member's Comments

No comment yet.

Related content which might interest you: Early detection of pulmonary exacerbations in children with cystic fibrosis by electronic home monitoring of symptoms and lung function Source: International Congress 2016 – Cystic fibrosis: monitoring and management Year: 2016 Factors associated with recurrence of severe exacerbations in Non-cystic fibrosis bronchiectasis in developping countries. Source: International Congress 2019 – Clinical problems Year: 2019 Predictive factors for severe pulmonary exacerbations in patients with cystic fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 715s Year: 2006 Non-cystic fibrosis bronchiectasis: etiology and predictors of exacerbations and mortality in patients across the largest health system in central and western Massachusetts Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies Year: 2017 Differences in clinical features and biomarkers of subsequent acute cystic fibrosis pulmonary exacerbations - Analysing exacerbations as separate entities Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013 Exacerbations, hospitalisations and mortality in patients with idiopathic pulmonary fibrosis in clinical practice: INSIGHTS-IPF registry Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): clinical problems Year: 2017 Assessing response to treatment of exacerbations of bronchiectasis in adults Source: Eur Respir J 2009; 33: 312-318 Year: 2009 Thoracic excursions as an effect parameter for in hospital treatment of pulmonary exacerbations in cystic fibrosis patients Source: Eur Respir J 2004; 24: Suppl. 48, 386s Year: 2004 Pulmonary arterial enlargement is a predictor of higher risk of exacerbations in non-cystic fibrosis bronchiectasis patients Source: Virtual Congress 2021 – Bronchiectasis Year: 2021 Prevalence of non-cystic fibrosis bronchiectasis in patients with severe asthma: a real-life study Source: Virtual Congress 2020 – Air pollution and comorbidities Year: 2020 Cytomegalovirus-associated pulmonary exacerbation in patients with cystic fibrosis Source: ERJ Open Res, 4 (1) 00111-2017; 10.1183/23120541.00111-2017 Year: 2018 Trends in healthcare utilization and costs prior to a chronic obstructive pulmonary disease (COPD) diagnosis Source: Eur Respir J 2006; 28: Suppl. 50, 36s Year: 2006 Home versus hospital treatment of acute cystic fibrosis pulmonary exacerbations – Is quality of life really better at home? Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children Year: 2013 Glucose tolerance during pulmonary exacerbations in children with cystic fibrosis Source: Annual Congress 2011 - Cystic fibrosis: new basic, clinical and bacteriological knowledge Year: 2011 Role of non-cystic fibrosis bronchiectasis in hospitalized patients with acute exacerbation of COPD Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies? Year: 2017 Frequent outpatient exacerbations of non cystic fibrosis bronchiectasis leads to impaired health related quality of life Source: Annual Congress 2007 - Different aspects of COPD exacerbations Year: 2007 The experience of patients with cystic fibrosis during pulmonary exacerbations: a mixed-method study Source: International Congress 2017 – Nursing practice across respiratory care pathways Year: 2017 Clinical characteristics of patients with Idiopathic pulmonary fibrosis in a tertiary care center of a developing country Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 Doxycycline improves clinical outcomes during cystic fibrosis exacerbations Source: Eur Respir J , 49 (4)  1601102; DOI: 10.1183/13993003.01102-2016 Year: 2017 Symptom duration and the lung clearance index in children with cystic fibrosis and pulmonary exacerbations Source: International Congress 2019 – Physiology of cystic fibrosis Year: 2019